Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
Messager, M ; de Steur, W ; Boelens, P G ; Jensen, L S ; Mariette, C ; Reynolds, J V ; Osorio, J ; Pera, M ; Johansson, Jan LU
and Kołodziejczyk, P
, et al.
(2016)
In European Journal of Surgical Oncology
42(9).
p.1432-1447
- Abstract
- Outcomes for patients with oesophago-gastric cancer are variable across Europe. The reasons for this variability are not clear. The aim of this study was to describe and analyse clinical pathways to understand differences in service provision for oesophageal and gastric cancer in the countries participating in the EURECCA Upper GI group.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8824947
- author
- Messager, M
; de Steur, W
; Boelens, P G
; Jensen, L S
; Mariette, C
; Reynolds, J V
; Osorio, J
; Pera, M
; Johansson, Jan
LU
and Kołodziejczyk, P
, et al. (More)
- Messager, M
; de Steur, W
; Boelens, P G
; Jensen, L S
; Mariette, C
; Reynolds, J V
; Osorio, J
; Pera, M
; Johansson, Jan
LU
; Kołodziejczyk, P
; Roviello, F
; De Manzoni, G
; Mönig, S P
and Allum, W H
(Less)
- organization
- publishing date
- 2016-02-06
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Surgical Oncology
- volume
- 42
- issue
- 9
- pages
- 1432 - 1447
- publisher
- Elsevier
- external identifiers
-
- pmid:26898839
- pmid:26898839
- wos:000383005100025
- scopus:84995545597
- ISSN
- 1532-2157
- DOI
- 10.1016/j.ejso.2016.01.001
- language
- English
- LU publication?
- yes
- id
- 92429933-1756-463a-9124-1b3f404efda0 (old id 8824947)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26898839?dopt=Abstract
- date added to LUP
- 2016-04-01 10:14:08
- date last changed
- 2024-10-06 23:43:46
@article{92429933-1756-463a-9124-1b3f404efda0,
abstract = {{Outcomes for patients with oesophago-gastric cancer are variable across Europe. The reasons for this variability are not clear. The aim of this study was to describe and analyse clinical pathways to understand differences in service provision for oesophageal and gastric cancer in the countries participating in the EURECCA Upper GI group.}},
author = {{Messager, M and de Steur, W and Boelens, P G and Jensen, L S and Mariette, C and Reynolds, J V and Osorio, J and Pera, M and Johansson, Jan and Kołodziejczyk, P and Roviello, F and De Manzoni, G and Mönig, S P and Allum, W H}},
issn = {{1532-2157}},
language = {{eng}},
month = {{02}},
number = {{9}},
pages = {{1432--1447}},
publisher = {{Elsevier}},
series = {{European Journal of Surgical Oncology}},
title = {{Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).}},
url = {{http://dx.doi.org/10.1016/j.ejso.2016.01.001}},
doi = {{10.1016/j.ejso.2016.01.001}},
volume = {{42}},
year = {{2016}},
}